MEDIFAST INC
corporate_fare Company Profile
MEDIFAST INC (NYSE:MED) is a publicly traded company in the Consumer Cyclical sector. Wiseek monitors MED SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Medifast Reports Worsening Q1 2026 Results with 34% Revenue Drop and Expanded Net Loss
- Medifast Forecasts Q2 Loss of $0.50-$1.00/Share Amid Continued Struggles
- Medifast Q1 Revenue Plunges 34% as Coach Count Drops 45%, Projects Continued Losses
- Medifast Reports Steep Q1 Revenue Decline, Increased Losses, and Negative 2026 Outlook Amid Industry Headwinds
- Medifast Amends Share Incentive Plan Proposal with Post-Exercise Holding Requirement Following ISS Feedback
monitoring Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$385.79M
Net Income
-$18.67M
Diluted EPS
-$1.70
Op. Cash Flow
$6.86M
Free Cash Flow
$1.25M
Gross Profit
$275.19M
Operating Income
-$14.21M
Cash & Equivalents
$89.3M
Debt / Equity
0.00×
Net Margin
-4.8%
Shares Outstanding
10.99M sh
Source: 10-K · filed 2026-02-17 · accession 0001628280-26-008656
supervised_user_circle Insider Transactions
$246.68K bought
Net $246.68K buying
· 4 transactions by 2 insiders · last 12 months
-
2026-05-11 SCHLACKMAN SCOTT DirectorOpen-market purchase 2.5K sh $31.32K @ $12.53
-
2026-05-08 SCHLACKMAN SCOTT DirectorOpen-market purchase 2.5K sh $31.63K @ $12.65
-
2026-03-20 Chard Daniel R Chairman & CEO Officer · DirectorOpen-market purchase 17.68K sh $178.72K @ $10.11
-
2025-06-13 Chard Daniel R Chairman & CEO Officer · DirectorOpen-market purchase 381 sh $5K @ $13.13
-
2026-03-25 Chard Daniel R Chairman & CEO Officer · DirectorGrant/Award 41.8K sh 2 fills
-
2026-03-25 Chard Daniel R Chairman & CEO Officer · DirectorTax/exercise cost 20.09K sh $192.71K @ $9.59
-
2026-03-25 Maloney James P. Chief Financial Officer OfficerTax/exercise cost 3.22K sh $30.92K @ $9.59
-
2026-03-25 Maloney James P. Chief Financial Officer OfficerGrant/Award 35.36K sh 2 fills
-
2026-03-25 MacKenzie Jonathan Barrett VP, Finance & CAO OfficerTax/exercise cost 862 sh $8.27K @ $9.59
-
2026-03-25 MacKenzie Jonathan Barrett VP, Finance & CAO OfficerGrant/Award 10.83K sh
-
2026-03-17 Chard Daniel R Chairman & CEO Officer · DirectorTax/exercise cost 2.64K sh $26.51K @ $10.05
-
2026-03-17 Maloney James P. Chief Financial Officer OfficerTax/exercise cost 482 sh $4.84K @ $10.05
-
2026-03-17 MacKenzie Jonathan Barrett VP, Finance & CAO OfficerTax/exercise cost 70 sh $703.5 @ $10.05
-
2026-03-13 Chard Daniel R Chairman & CEO Officer · DirectorTax/exercise cost 7.08K sh $68.06K @ $9.62
-
2026-03-13 Maloney James P. Chief Financial Officer OfficerTax/exercise cost 918 sh $8.83K @ $9.62
-
2026-03-13 MacKenzie Jonathan Barrett VP, Finance & CAO OfficerTax/exercise cost 198 sh $1.9K @ $9.62
-
2025-06-25 BROWN JEFFREY J DirectorGrant/Award 20.62K sh $126.53K 2 fills, avg $6.14
-
2025-06-25 SCHLACKMAN SCOTT DirectorGrant/Award 11.17K sh
-
2025-06-25 Hoer Michael A. DirectorGrant/Award 11.17K sh
-
2025-06-25 Xian Ming DirectorGrant/Award 17.18K sh $80.52K 2 fills, avg $4.69 derivative
-
2025-06-25 Thomas Andrea B DirectorGrant/Award 11.17K sh
-
2025-06-25 Geary Elizabeth A. DirectorGrant/Award 11.17K sh
From SEC Form 4 + 5 (insider beneficial-ownership filings) · last 12 months · view all on SEC EDGAR ↑
show_chartPrice Chart
Loading chart...
feed MED - Latest Insights
MED
May 04, 2026, 4:51 PM EDT
MED
May 04, 2026, 4:32 PM EDT
MED
May 04, 2026, 4:17 PM EDT
MED
May 04, 2026, 4:12 PM EDT
MED
Apr 30, 2026, 9:24 AM EDT
MED
Apr 06, 2026, 4:06 PM EDT
MED
Mar 27, 2026, 5:51 PM EDT
MED
Mar 20, 2026, 12:55 PM EDT
MED
Mar 20, 2026, 8:35 AM EDT
MED
Feb 17, 2026, 4:54 PM EST
MED
Feb 17, 2026, 4:44 PM EST
MED
Jan 05, 2026, 9:02 AM EST